|
000
| 02313nam 2200349zi 4500 |
|---|
| 001 | 9.932074 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240308105510 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240104e201405##oncad ob f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-491/2014E-PDF |
|---|
| 245 | 00|aEvaluation of the Biologics Program 1999-2000 to 2012-2013 / |cprepared by Evaluation Directorate, Health Canada and the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMay 2014. |
|---|
| 300 | |a1 online resource (xx, 150 pages) : |billustrations, graphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Évaluation du Programme des produits biologiques de 1999-2000 à 2012-2013. |
|---|
| 504 | |aIncludes bibliographical references (pages 121-130, pages 148-150). |
|---|
| 520 | |a"The Biologics Program (BP) is managed through the Health Products and Food Branch (HPFB) of Health Canada. The BP regulates drugs and products derived from living sources, as well as radiopharmaceuticals. Products derived from living sources include blood and blood components and blood products; vaccines; hormones; enzymes; cytokines; monoclonal antibodies; gene therapy products; cells, tissues, and organs; xenografts; and semen for assisted conception"--Executive summary, page ii. |
|---|
| 650 | 0|aBiologicals|zCanada|xEvaluation. |
|---|
| 650 | 0|aBiologicals|xRisk assessment|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bEvaluation Directorate, |eissuing body. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |bEvaluation Directorate, |eissuing body. |
|---|
| 775 | 08|tÉvaluation du Programme des produits biologiques de 1999-2000 à 2012-2013 / |w(CaOODSP)9.935132 |
|---|
| 856 | 40|qPDF|s840 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-491-2014-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/about-health-canada/accountability-performance-financial-reporting/evaluation-reports/evaluation-biologics-program-1999-2000-2012-2013.html |
|---|